Position in REGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$20,682,197
-$1,565,198 QoQ
Shares Held
33,169
+15.2% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#212
of 1,327 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. REGN ranks #2 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,525 | $40,495,910 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
33,169 | $20,682,197 | |
| 3 | MRNA |
Moderna, Inc.
|
87,541 | $6,130,496 | |
| 4 | BNTX |
BioNTech SE
|
61,238 | $5,698,195 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
153,242 | $4,018,005 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
35,363 | $2,633,836 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
40,000 | $2,517,600 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
146,762 | $2,166,207 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,682,197 | 33,169 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $22,247,395 | 28,794 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $10,453,434 | 13,543 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,826,802 | 10,363 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $3,938,550 | 7,502 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $4,654,612 | 7,339 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $4,600,226 | 6,458 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $4,347,927 | 4,136 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $4,627,684 | 4,403 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,580,461 | 3,720 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,228,965 | 4,815 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $7,135,063 | 8,670 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $5,033,371 | 7,005 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $5,838,786 | 7,106 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $5,839,738 | 8,094 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,082,931 | 5,927 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $3,762,542 | 6,365 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $5,273,768 | 7,551 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,419,095 | 11,748 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,087,624 | 13,364 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $7,156,571 | 12,813 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $6,644,304 | 14,043 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $6,388,163 | 13,223 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||